TOTALL: high cost of allergic rhinitis-a national Swedish population-based questionnaire study.
(2016) In npj Primary Care Respiratory Medicine 26. p.15082-15082- Abstract
- Allergic rhinitis is a global illness with a well-recognised impact on quality of life and work performance. Comparatively little is known about the extent of its economic impact on society. The TOTALL study estimates the total cost of allergic rhinitis using a sample representing the entire Swedish population of working age. A questionnaire focused on allergic rhinitis was mailed out to a random population of Swedish residents, aged 18-65 years. Health-care contacts, medications, absenteeism (absence from work) and presenteeism (reduced working capacity at work) were assessed, and the direct and indirect costs of allergic rhinitis were calculated. Medication use was evaluated in relation to the ARIA guidelines. In all, 3,501 of 8,001... (More)
- Allergic rhinitis is a global illness with a well-recognised impact on quality of life and work performance. Comparatively little is known about the extent of its economic impact on society. The TOTALL study estimates the total cost of allergic rhinitis using a sample representing the entire Swedish population of working age. A questionnaire focused on allergic rhinitis was mailed out to a random population of Swedish residents, aged 18-65 years. Health-care contacts, medications, absenteeism (absence from work) and presenteeism (reduced working capacity at work) were assessed, and the direct and indirect costs of allergic rhinitis were calculated. Medication use was evaluated in relation to the ARIA guidelines. In all, 3,501 of 8,001 (44%) answered the questionnaire, and 855 (24%) of these reported allergic rhinitis. The mean annual direct and indirect costs because of allergic rhinitis were €210.3 and €750.8, respectively, resulting in a total cost of €961.1 per individual/year. Presenteeism represented 70% of the total cost. Antihistamines appear to be used in excess in relation to topical steroids, and the use of nasal decongestants was alarmingly high. The total cost of allergic rhinitis in Sweden, with a population of 9.5 million, was estimated at €1.3 billion annually. These unexpectedly high costs could be related to the high prevalence of disease, in combination with the previously often underestimated indirect costs. Improved adherence to guidelines might ease the economic burden on society. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/8829306
- author
- Cardell, Lars-Olaf ; Olsson, Petter ; Andersson, Morgan LU ; Welin, Karl-Olof ; Svensson, Johanna ; Ragnarson Tennvall, Gunnel LU and Hellgren, Johan
- organization
- publishing date
- 2016
- type
- Contribution to journal
- publication status
- published
- subject
- in
- npj Primary Care Respiratory Medicine
- volume
- 26
- pages
- 15082 - 15082
- publisher
- Nature Publishing Group
- external identifiers
-
- pmid:26845513
- scopus:84957579765
- wos:000369423300001
- pmid:26845513
- ISSN
- 2055-1010
- DOI
- 10.1038/npjpcrm.2015.82
- language
- English
- LU publication?
- yes
- id
- 05a2a14f-f173-4ecb-a182-860cd35bb324 (old id 8829306)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/26845513?dopt=Abstract
- date added to LUP
- 2016-04-04 09:39:05
- date last changed
- 2022-04-23 21:28:16
@article{05a2a14f-f173-4ecb-a182-860cd35bb324,
abstract = {{Allergic rhinitis is a global illness with a well-recognised impact on quality of life and work performance. Comparatively little is known about the extent of its economic impact on society. The TOTALL study estimates the total cost of allergic rhinitis using a sample representing the entire Swedish population of working age. A questionnaire focused on allergic rhinitis was mailed out to a random population of Swedish residents, aged 18-65 years. Health-care contacts, medications, absenteeism (absence from work) and presenteeism (reduced working capacity at work) were assessed, and the direct and indirect costs of allergic rhinitis were calculated. Medication use was evaluated in relation to the ARIA guidelines. In all, 3,501 of 8,001 (44%) answered the questionnaire, and 855 (24%) of these reported allergic rhinitis. The mean annual direct and indirect costs because of allergic rhinitis were €210.3 and €750.8, respectively, resulting in a total cost of €961.1 per individual/year. Presenteeism represented 70% of the total cost. Antihistamines appear to be used in excess in relation to topical steroids, and the use of nasal decongestants was alarmingly high. The total cost of allergic rhinitis in Sweden, with a population of 9.5 million, was estimated at €1.3 billion annually. These unexpectedly high costs could be related to the high prevalence of disease, in combination with the previously often underestimated indirect costs. Improved adherence to guidelines might ease the economic burden on society.}},
author = {{Cardell, Lars-Olaf and Olsson, Petter and Andersson, Morgan and Welin, Karl-Olof and Svensson, Johanna and Ragnarson Tennvall, Gunnel and Hellgren, Johan}},
issn = {{2055-1010}},
language = {{eng}},
pages = {{15082--15082}},
publisher = {{Nature Publishing Group}},
series = {{npj Primary Care Respiratory Medicine}},
title = {{TOTALL: high cost of allergic rhinitis-a national Swedish population-based questionnaire study.}},
url = {{http://dx.doi.org/10.1038/npjpcrm.2015.82}},
doi = {{10.1038/npjpcrm.2015.82}},
volume = {{26}},
year = {{2016}},
}